Cargando…
A Binding-Site Barrier Affects Imaging Efficiency of High Affinity Amyloid-Reactive Peptide Radiotracers In Vivo
Amyloid is a complex pathology associated with a growing number of diseases including Alzheimer’s disease, type 2 diabetes, rheumatoid arthritis, and myeloma. The distribution and extent of amyloid deposition in body organs establishes the prognosis and can define treatment options; therefore, deter...
Autores principales: | Wall, Jonathan S., Williams, Angela, Richey, Tina, Stuckey, Alan, Huang, Ying, Wooliver, Craig, Macy, Sallie, Heidel, Eric, Gupta, Neil, Lee, Angela, Rader, Brianna, Martin, Emily B., Kennel, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672142/ https://www.ncbi.nlm.nih.gov/pubmed/23750281 http://dx.doi.org/10.1371/journal.pone.0066181 |
Ejemplares similares
-
A Peptide-Fc Opsonin with Pan-Amyloid Reactivity
por: Foster, James S., et al.
Publicado: (2017) -
Evaluation of the effect of d-amino acid incorporation into amyloid-reactive peptides
por: Martin, Emily B., et al.
Publicado: (2017) -
Development and characterization of a prototypic pan-amyloid clearing agent – a novel murine peptide-immunoglobulin fusion
por: Foster, James S., et al.
Publicado: (2023) -
Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis
por: Wall, Jonathan S., et al.
Publicado: (2015) -
Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide (124)I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging
por: Martin, Emily B., et al.
Publicado: (2023)